Regulation - Research, AbbVie

Filter

Current filters:

ResearchAbbVie

Popular Filters

FDA investigating risk of stroke, heart attack and death with testosterone products

FDA investigating risk of stroke, heart attack and death with testosterone products

03-02-2014

The US Food and Drug Administration said on Friday that it is investigating the risk of stroke, heart…

AbbVieActavisAndrodermAndroGelAxironEli LillyMen's HealthNorth AmericaPharmaceuticalRegulationResearchTestosteroneUSA

US FDA grants "Breakthrough" status for AbbVie's HCV regimen

06-05-2013

US drugmaker AbbVie (NYSE: ABBV) says that its investigational direct-acting antiviral (DAA) combination…

AbbVieAnti-viralsPharmaceuticalRegulationResearch

Court stops EMA from disclosing clinical trial documents from AbbVie and InterMune

01-05-2013

The European Medicines Agency has been ordered by the General Court of the European Union not to provide…

AbbVieEuropeInterMuneLegalPharmaceuticalRegulationResearch

Back to top